February 11, 2014
Accenture Positioned as a Leader in an IDC MarketScape Worldwide Life Sciences Manufacturing and Supply Chain Vendor Assessment on Business Process Outsourcing
NEW YORK; February 11, 2014 – Accenture (NYSE:ACN) is positioned as a Leader in an IDC Health Insights vendor assessment covering business process outsourcing (BPO) across the life sciences manufacturing and supply chain industry.
The report, “IDC MarketScape: Worldwide Life Science Manufacturing and Supply Chain Business BPO2013 Vendor Assessment" (#HI244446), provides an assessment of the life science manufacturing and supply industry and market trends, comparing major vendors and assesses the criteria that are most important for life science companies to consider when selecting a service provider.
For the purposes of this analysis, IDC Health Insights divided potential key measures for success into two primary categories: capabilities and strategies. The assessment includes client references. While nearly 20 vendors were considered, a total of five vendors were invited to participate in the vendor assessment.
Hussain Mooraj, global managing director of Accenture’s Life Sciences Enterprise and Supply Chain practice said, “We are pleased to be recognized as a Leader in this IDC MarketScape vendor assessment on BPO. With products going off patent in pharma - hampered by the ability to scale in biotech and changing customer dynamics in the med tech industry - the role of supply chain is critical. We are committed to helping our clients achieve speed to value by moving beyond their traditional one-size-fits-all approach to supply chains.”
In naming Accenture as a Leader, the IDC MarketScape stated, “Accenture has a strong track record of engaging with its clients under flexible pricing contracts (i.e., profit or risk sharing), which should provide it increasing opportunities going forward as the life science industry continues to become more interested in these types of arrangements and migrate toward this model.”
Accenture has also been positioned as a Leader in two other recent IDC MarketScapes. These are:
- IDC MarketScape: Worldwide Life Science Sales and Marketing Strategic Consulting 2013 Vendor Assessment (#HI244309)
- IDC MarketScape: Worldwide Life Science Sales and Marketing IT Outsourcing (ITO) 2013 Vendor Assessment (#HI243591)
Source: IDC Health Insights, 2013
The IDC MarketScape Capabilities score measures vendor product, go-to-market and business execution in the short-term. The Strategy score measures alignment of vendor strategies with customer requirements in a 3-5-year timeframe. Vendor market share is represented by the size of the circles. Vendor year-over-year growth rate relative to the given market is indicated by a plus, neutral or minus next to the vendor name.
Click here to learn more about Accenture’s Life Sciences practice.
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of IT, telecommunications, or industry-specific suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT, telecommunications, or industry-specific vendors can be meaningfully compared. The framework also provides technology buyers with a transparent foundation to allow companies to independently compare the strengths and weaknesses of current and prospective vendors.
Accenture is a global management consulting, technology services and outsourcing company, with approximately 281,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world’s most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$28.6 billion for the fiscal year ended Aug. 31, 2013. Its home page is www.accenture.com
# # #
+ 312 693 5992
+44 7810 756 138